APA (7th ed.) Citation

R, M., R, Z., A, F., J, T., M, U., MU, A., . . . P, B. (2025). Efficacy and safety of perfluorohexyloctane (PFHO) in patients with dry eye disease (DED) due to meibomian gland dysfunction (MGD): Systematic review and meta-analysis. Medicine, 104(29), e43026. https://doi.org/10.1097/MD.0000000000043026

Chicago Style (17th ed.) Citation

R, Munsab, Zafar R, Fatima A, Taj J, Usman M, Anjum MU, Hasanain M, and Bhattarai P. "Efficacy and Safety of Perfluorohexyloctane (PFHO) in Patients with Dry Eye Disease (DED) Due to Meibomian Gland Dysfunction (MGD): Systematic Review and Meta-analysis." Medicine 104, no. 29 (2025): e43026. https://doi.org/10.1097/MD.0000000000043026.

MLA (9th ed.) Citation

R, Munsab, et al. "Efficacy and Safety of Perfluorohexyloctane (PFHO) in Patients with Dry Eye Disease (DED) Due to Meibomian Gland Dysfunction (MGD): Systematic Review and Meta-analysis." Medicine, vol. 104, no. 29, 2025, p. e43026, https://doi.org/10.1097/MD.0000000000043026.